Finance

Lists
Why is CGTX down 7,17%?
Dive Deeper
CGTX:NASDAQ
Cognition Therapeutics Inc
0,89 $
-7,17%
(-0,069) 1D
0,90 $
+1,21% (+0,011)
After hours
Closed: 1 қаз., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CGTX...
Open
0,98 $
High
0,99 $
Low
0,89 $
Mkt. cap
84,75 млн
Avg. vol.
400,08 м.
Volume
84,00
52-wk high
2,05 $
52-wk low
0,55 $
EPS
-0,20 $
Beta
1,79
Shares outstanding
95,09 млн
No. of employees
14
Open
0,98 $
High
0,99 $
Low
0,89 $
Mkt. cap
84,75 млн
Avg. vol.
400,08 м.
Volume
84,00
52-wk high
2,05 $
52-wk low
0,55 $
EPS
-0,20 $
Beta
1,79
Shares outstanding
95,09 млн
No. of employees
14
News stories
From web sources and news partners
www.marketscreener.com
www.marketscreener.com
·
15 минут бұрын
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ChartMill
ChartMill
·
55 минут бұрын
Nutanix (NASDAQ:NTNX): Strong Growth Meets a High-Quality Technical Setup
Investor's Business Daily
Investor's Business Daily
·
46 минут бұрын
Twilio To Join S&P 500 Index
Seeking Alpha
Seeking Alpha
·
15 минут бұрын
S&P 500's Trajectory Stayed Above Its Mean Trendline In September 2026
About Cognition Therapeutics Inc
CEO-
Employees14
Founded2007 ж. 01 қаң.
Headquarters-
SectorPharmaceutical industry
Websitecogrx.com
Analyst ratings
Based on 1 analyst giving stock ratings to CGTX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CGTX in the last 3 months
Highest
Current 0,89 $
3,00 $ (+236,62%)
Average
3,00 $ (+236,62%)
Lowest
3,00 $ (+236,62%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Maintained
3,00 $
+236,6%
09/21/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
4,00 $
+348,8%
05/08/2026
William Wood
B. Riley Securities
Buy
Maintained
3,00 $
+236,6%
11/21/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3,77 млн
11,15 млн
6,12 млн
5,10 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,60 млн
2,52 млн
2,70 млн
2,64 млн
Operating expense
6,38 млн
13,67 млн
8,82 млн
7,74 млн
Total operating expenses
6,38 млн
13,67 млн
8,82 млн
7,74 млн
Operating income
-6,38 млн
-13,67 млн
-8,82 млн
-7,74 млн
Other non operating income
1,44 млн
10,33 млн
4,25 млн
3,81 млн
EBT including unusual items
-4,93 млн
-3,34 млн
-4,57 млн
-3,93 млн
EBT excluding unusual items
-4,93 млн
-3,34 млн
-4,57 млн
-3,93 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4,93 млн
-3,34 млн
-4,57 млн
-3,93 млн
Net profit margin
-
-
-
-
Earnings per share
-0,06
-0,02
-0,05
-0,04
Interest and investment income
-
-
-
-
Interest expense
-
-5,00 мың
-5,00 мың
-3,00 мың
Net interest expenses
-
-5,00 мың
-5,00 мың
-3,00 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,36 млн
-13,66 млн
-8,81 млн
-7,73 млн
Gain or loss from assets sale
-
41,00 мың
5,00 мың
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары